These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27884752)

  • 1. Quantitative proteomic analysis reveals that proteins required for fatty acid metabolism may serve as diagnostic markers for gastric cancer.
    Jiang Z; Shen H; Tang B; Yu Q; Ji X; Wang L
    Clin Chim Acta; 2017 Jan; 464():148-154. PubMed ID: 27884752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of diagnostic markers involved in the pathogenesis of gastric cancer through iTRAQ-based quantitative proteomics.
    Jiang Z; Shen H; Tang B; Chen H; Yu Q; Ji X; Wang L
    Data Brief; 2017 Apr; 11():122-126. PubMed ID: 28180141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers that involved in the epigenetic transcriptional regulation for detection gastric cancer by iTRAQ based quantitative proteomic analysis.
    Jiang Z; Sun X; Zhang Q; Ji X; Yu Q; Huang T; Chen D; Chen H; Mei X; Wang L; He L; Fang J; Hou L; Wang L
    Clin Chim Acta; 2017 Aug; 471():29-37. PubMed ID: 28502558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
    Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
    J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer.
    Jiang Z; Zhang C; Gan L; Jia Y; Xiong Y; Chen Y; Wang Z; Wang L; Luo H; Li J; Zhu R; Ji X; Yu Q; Wang L
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800038. PubMed ID: 30485682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer.
    Duan J; Sun L; Huang H; Wu Z; Wang L; Liao W
    Mol Med Rep; 2016 Apr; 13(4):3027-35. PubMed ID: 26936091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
    Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
    Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of PGLS as a metabolic target for early screening and prognostic monitoring of gastric cancer.
    Yuan X; Xiao Y; Luo Y; Wei C; Wang J; Huang J; Liao W; Song S; Jiang Z
    J Clin Lab Anal; 2022 Feb; 36(2):e24189. PubMed ID: 34953081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative proteomics study on olfactomedin 4 in the development of gastric cancer.
    Ran X; Xu X; Yang Y; She S; Yang M; Li S; Peng H; Ding X; Hu H; Hu P; Zhang D; Ren H; Wu L; Zeng W
    Int J Oncol; 2015 Nov; 47(5):1932-44. PubMed ID: 26398045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
    Tseng CW; Yang JC; Chen CN; Huang HC; Chuang KN; Lin CC; Lai HS; Lee PH; Chang KJ; Juan HF
    Proteomics; 2011 Jun; 11(12):2423-39. PubMed ID: 21598387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomics analysis of gastric cancer stem cells.
    Morisaki T; Yashiro M; Kakehashi A; Inagaki A; Kinoshita H; Fukuoka T; Kasashima H; Masuda G; Sakurai K; Kubo N; Muguruma K; Ohira M; Wanibuchi H; Hirakawa K
    PLoS One; 2014; 9(11):e110736. PubMed ID: 25379943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
    Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
    Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
    Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
    Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer.
    Wei C; Xie J; Yuan X; Luo Y; Xiao Y; Liao W; Jiang Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24718. PubMed ID: 36181311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Proteomics Approach Reveals Voltage-Dependent Anion Channel 1 (VDAC1) as a Potential Biomarker of Gastric Cancer.
    Gao W; Xua J; Wang F; Zhang L; Peng R; Zhu Y; Tang Q; Wu J
    Cell Physiol Biochem; 2015; 37(6):2339-54. PubMed ID: 26646027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Proteomic Profiling of Extracellular Proteins between Normal and Gastric Cancer Cells.
    Kang M; Lu S; Chong PK; Yeoh KG; Lim YP
    Curr Cancer Drug Targets; 2016; 16(5):442-54. PubMed ID: 26648486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
    He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
    World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma membrane proteomic analysis of human Gastric Cancer tissues: revealing flotillin 1 as a marker for Gastric Cancer.
    Gao W; Xu J; Wang F; Zhang L; Peng R; Shu Y; Wu J; Tang Q; Zhu Y
    BMC Cancer; 2015 May; 15():367. PubMed ID: 25948494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.